Hepatology
Commentary
HCV screening in pregnancy: Reducing the risk for casualties in the quest for elimination
HCV screening during pregnancy, as currently recommended, provides no immediate benefit for the pregnant woman or the fetus/neonate, given that...
Conference Coverage
In pill or food form, healthy fatty acids reduce liver fat
For patients with NAFLD who supplement their diets with polyunsaturated fatty acids, liver and metabolic parameters improve, results of a...
Latest News
HCV in pregnancy: One piece of a bigger problem
“These data also enable us to step back a bit from HCV and look at the landscape of how the opioid crisis continues to grow in complexity and...
From the Journals
Drink up: Large study confirms coffee beneficial to liver health
“This is the closest we’re ever going to get to a linkage between what people are eating or drinking and the health of their liver.”
Feature
Pandemic adds more weight to burden of obesity in children
“Our nation’s safety net is fragile, outdated, and out of reach for millions of eligible kids and caregivers,” said an author of a new report.
Feature
Call to Action: Multidisciplinary panel urges coordinated care for ‘NASH epidemic’
Livin' on the MDedge
The most important meal of the day, with extra zinc
Plus, livers live the hop life and babies get scared by their microbiomes.
From the Journals
Third COVID-19 vaccine dose helped some transplant recipients
All of those with low titers before the third dose had high titers after receiving the extra shot, in case series.
From the Journals
Waist circumference a marker for NAFL in type 1 diabetes
A cross-sectional study has found that waist-to-height ratio is a sensitive marker for nonalcoholic fatty liver in type 1 diabetes.
From the Journals
Guidelines highlight drug- and herb-induced liver injuries
Leading causes of idiosyncratic drug-induced liver injury include antimicrobials, herbal and dietary supplements, and cancer treatments.
Conference Coverage
Do anti–apo A-I antibodies link fatty liver disease and CVD?
Anti–apo A-I antibodies appear to be common in patients with NAFLD and may drive both fat deposits and proinflammatory effects in liver cells,...